Phase 2 Enabling Toxicology Studies of MW151, A Selective Small Molecule Suppressor of Neuroinflammation for Alzheimer’s Disease

Project Number
Agency/Funding Organization
Alzheimer's Drug Discovery Foundation
Funding Year
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Principal Investigator Last Name
Van Eldik
Awardee State
Contact PI Country
Project Detail
Funding Opportunity Announcement
FY Overall Cost
Funding Organization
Agency/Funding Organization
Funding Organization Country